** Medical equipment maker Agilent Technologies' A.N shares up 1.9% at $141.35
** Jefferies raises PT to $130 from $120, maintains "hold" rating
** New PT represents 6.7% upside to stock's last close
** Brokerage expects Agilent's new Altura columns — used for biotherapeutic applications — to drive higher prices and incremental growth in their consumables business
** Also notes co feels the launch gives Agilent more ways to win on pricing and market share, and is strategically important for supporting future growth and margins
** Agilent Technologies is expected to benefit from higher pricing on its newly launched Altura Ultra Inert HPLC columns, with initial checks indicating prices about 20% above comparable products, says Jefferies
** Nine of 20 brokerages rate stock "buy" or higher, 11 "hold"; median PT is $140 — LSEG data
** Including session's moves, stock up ~5.2% YTD
(Reporting by Anuj T in Bengaluru)
((anuj.t@thomsonreuters.com))